Investment
SQURPHARMA Approves Factory BMRE Investment
SQURPHARMA approved a factory BMRE investment.
SQURPHARMAPharmaceuticals & Chemicals
Follow the latest news and corporate disclosures of Square Pharmaceuticals PLC. (DSE: SQURPHARMA), including board meetings, quarterly financial results, dividend decisions, record dates, AGM notices and regulatory updates.
SQURPHARMA approved a factory BMRE investment.
SQURPHARMA will hold a board meeting on 22 October 2020 at 3:00 PM.
SQURPHARMA published a corporate disclosure on 9 June 2020. Read the full announcement for details.
SQURPHARMA will hold a board meeting on 8 June 2020 at 3:00 PM.
SQURPHARMA published a corporate disclosure on 24 March 2020. Read the full announcement for details.
SQURPHARMA published a corporate disclosure on 27 February 2020. Read the full announcement for details.
SQURPHARMA published a corporate disclosure on 27 February 2020. Read the full announcement for details.
SQURPHARMA published a corporate disclosure on 23 February 2020. Read the full announcement for details.
SQURPHARMA published a corporate disclosure on 23 February 2020. Read the full announcement for details.
SQURPHARMA published a corporate disclosure on 18 February 2020. Read the full announcement for details.